Moors & Cabot’s Omega Healthcare OHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $300K | Hold |
6,855
| – | – | 0.01% | 700 |
|
|
2025
Q4 | $304K | Sell |
6,855
-92
| -1% | -$3.96K | 0.01% | 679 |
|
|
2025
Q3 | $293K | Sell |
6,947
-196
| -3% | -$7.9K | 0.01% | 680 |
|
|
2025
Q2 | $262K | Buy |
+7,143
| New | +$265K | 0.01% | 703 |
|
|
2023
Q4 | – | Sell |
-6,131
| Closed | -$203K | – | 881 |
|
|
2023
Q3 | $203K | Buy |
+6,131
| New | +$196K | 0.01% | 744 |
|
|
2023
Q1 | – | Sell |
-8,052
| Closed | -$225K | – | 916 |
|
|
2022
Q4 | $225K | Sell |
8,052
-500
| -6% | -$15.1K | 0.02% | 696 |
|
|
2022
Q3 | $252K | Buy |
8,552
+102
| +1% | +$3.2K | 0.02% | 626 |
|
|
2022
Q2 | $238K | Buy |
8,450
+503
| +6% | +$14.3K | 0.02% | 641 |
|
|
2022
Q1 | $248K | Buy |
+7,947
| New | +$234K | 0.02% | 703 |
|
|
2021
Q4 | – | Sell |
-22,436
| Closed | -$668K | – | 951 |
|
|
2021
Q3 | $668K | Buy |
22,436
+12,316
| +122% | +$424K | 0.04% | 372 |
|
|
2021
Q2 | $367K | Buy |
10,120
+87
| +0.9% | +$3.23K | 0.03% | 511 |
|
|
2021
Q1 | $366K | Buy |
10,033
+4,468
| +80% | +$164K | 0.03% | 477 |
|
|
2020
Q4 | $202K | Buy |
+5,565
| New | +$189K | 0.02% | 655 |
|
|
2020
Q1 | – | Sell |
-7,372
| Closed | -$309K | – | 666 |
|
|
2019
Q4 | $309K | Sell |
7,372
-1,051
| -12% | -$44.5K | 0.03% | 456 |
|
|
2019
Q3 | $351K | Buy |
8,423
+1,108
| +15% | +$43.2K | 0.04% | 410 |
|
|
2019
Q2 | $264K | Buy |
7,315
+653
| +10% | +$23.8K | 0.03% | 441 |
|
|
2019
Q1 | $256K | Sell |
6,662
-1,185
| -15% | -$43.9K | 0.03% | 432 |
|
|
2018
Q4 | $277K | Sell |
7,847
-1,762
| -18% | -$61.1K | 0.04% | 381 |
|
|
2018
Q3 | $317K | Sell |
9,609
-1,666
| -15% | -$53K | 0.04% | 413 |
|
|
2018
Q2 | $351K | Buy |
11,275
+975
| +9% | +$27.9K | 0.05% | 382 |
|
|
2018
Q1 | $279K | Sell |
10,300
-254
| -2% | -$6.77K | 0.04% | 450 |
|
|
2017
Q4 | $296K | Buy |
10,554
+1,115
| +12% | +$32.2K | 0.04% | 420 |
|
|
2017
Q3 | $302K | Buy |
9,439
+610
| +7% | +$19.5K | 0.04% | 408 |
|
|
2017
Q2 | $295K | Buy |
8,829
+859
| +11% | +$28.4K | 0.05% | 395 |
|
|
2017
Q1 | $261K | Sell |
7,970
-2,545
| -24% | -$81.7K | 0.04% | 405 |
|
|
2016
Q4 | $330K | Buy |
10,515
+2,564
| +32% | +$79.1K | 0.05% | 361 |
|
|
2016
Q3 | $282K | Buy |
7,951
+667
| +9% | +$23.7K | 0.05% | 392 |
|
|
2016
Q2 | $247K | Buy |
7,284
+1,515
| +26% | +$50.6K | 0.04% | 409 |
|
|
2016
Q1 | $203K | Sell |
5,769
-100
| -2% | -$3.27K | 0.04% | 444 |
|
|
2015
Q4 | $203K | Sell |
5,869
-58
| -1% | -$2K | 0.04% | 444 |
|
|
2015
Q3 | $209K | Sell |
5,927
-637
| -10% | -$22.4K | 0.04% | 446 |
|
|
2015
Q2 | $227K | Buy |
6,564
+1,359
| +26% | +$49.9K | 0.04% | 446 |
|
|
2015
Q1 | $212K | Buy |
5,205
+11
| +0.2% | +$455 | 0.04% | 449 |
|
|
2014
Q4 | $206K | Buy |
+5,194
| New | +$197K | 0.03% | 448 |
|
Other funds holding OHI
VPM
VCM
Moors & Cabot's OHI Position: Q1 2026 in Review
Moors & Cabot held its Omega Healthcare (OHI) position steady in Q1 2026 at 6,855 shares worth $300K. The position accounts for 0.01% of the portfolio, ranked #700.
Moors & Cabot first reported a position in OHI in Q4 2014 and has held it in 34 quarters since. The position peaked at $668K in Q3 2021. 743 funds tracked by Wall St. Rank hold OHI as of Q1 2026.
- Moors & Cabot held 6,855 shares of Omega Healthcare worth $300K as of Q1 2026.
- Moors & Cabot left its Omega Healthcare share count unchanged in Q1 2026.
- Omega Healthcare made up 0.01% of Moors & Cabot's portfolio in Q1 2026, its #700 holding.
- Moors & Cabot first reported a position in Omega Healthcare in Q4 2014 and has held it in 34 quarters since.
- Moors & Cabot's Omega Healthcare position peaked at $668K in Q3 2021.
- 743 funds tracked by Wall St. Rank held Omega Healthcare as of Q1 2026.
Based on Moors & Cabot's 13F filing for Q1 2026, filed 8 May 2026.